Is President in your pocket? Sena asks BJP

Agencies
November 2, 2019

Mumbai, Nov 2: The Shiv Sena on Saturday slammed senior BJP leader Sudhir Mungantiwar for his statement that Maharashtra may head for President's rule if the new government is not put in place by November 7 and sarcastically questioned the senior ally whether the President's seal was lying at its office in the state.

The Sena, which is locked in a bitter battle with the BJP over sharing of power since the results of the assembly elections were declared on October 24, also dared its senior ally to stake claim to form the next government.

The tenure of the current Legislative Assembly ends on November 8.

Terming Sena's demand for chief minister's post on a rotational basis with the BJP as the "main hurdle" in government formation, Mungantiwar had said, "A new government will have to be in place within the stipulated time, or else the President will have to intervene. President's rule will be imposed if the government formation doesn't happen in the given time."

Attacking Mungantiwar, the Finance minister in the outgoing government, Sena said he issued the "threat" of imposing the President's rule, like other "intimidation tactics" like using investigating agencies for settling political scores have fallen flat in Maharashtra.

"What the common people have to make out of the threat given by Mungantiwar? Is that supposed to mean that President of India is in our (BJP's) pocket or that the seal of the President is lying in the office of the BJP in Maharashtra?

"Are these people trying to convey that the BJP could impose the President's rule in Maharashtra using that seal in the event of that party not able to form its government?" the Sena questioned in the edit in the party mouthpiece "Saamana".

The Marathi editorial titled "Insult to Maharashtra, Is President in your pocket?" described Mungantiwar's comments "undemocratic and unconstitutional."

"The statement shows the lack of knowledge about the Constitution and the rule of law. This threat might be a move to sidestep the established norms and get things done the way one wants. This statement is an insult to the mandate of the people," the party said.

In the October 21 assembly polls, the BJP failed to perform up to the mark though it emerged as the single largest party by winning 105 seats, 17 less than the 2014 tally, in the 288-member House. The ally Sena won 56 seats, 7 less than its 2014 performance.

The halfway mark in the Legislative Assembly is 145.

"The attitude that only we will rule irrespective of numbers and no one else can attempt the formation of the government was defeated in the recent elections," the Sena said.

The edit further said that those talking about the President's rule should first stake claim to form the government in the state.

"The President is the supreme authority in the Constitution. It is not about an individual but the country. The country is not in anybody's pocket," the editorial said.

The Sena also said it should not be blamed for the present impasse over formation of the government.

"There is no morality left in public life," it said.

Interestingly, Sharad Pawar-led NCP too on Friday criticised Mungantiwar's statement as a "kind of threat."

The Sena's fresh attack on the BJP on Saturday is likely to further strain the soured relations between both the parties.

The Uddhav Thackeray-led party has been demanding the CM's post for 2.5 years and 50:50 division of portfolios, as the BJP's tally took a beating in the polls.

Both these demands have been rejected by the BJP which has insisted that Chief Minister Devendra Fadnavis will continue to hold the post for the next five years.

Thackeray had reportedly said that other options (read NCP and Congress) are available for his party.

However, the Sharad Pawar-led NCP, which won 54 seats in the polls, had said that it would sit in the Opposition.

The Congress, which has 44 MLAs, seems to have adopted a wait-and-watch policy.

Top Congress leaders from Maharashtra on Friday held meetings in Delhi and discussed the situation with party president Sonia Gandhi.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 9,2020

New Delhi, Jan 9: JNU students who tried to march towards the Rashtrapati Bhavan on Thursday protesting the violence on the university campus were stopped by police and later detained.

The police also resorted to baton charge to control the mob who tried to block the traffic at Janpath. Using loudspeakers, the police also appealed to the crowd to maintain peace.

Before the students tried to proceed towards the Rashtrapati Bhavan, a delegation of JNU Students' Union and JNU Teachers' Association also met Human Resource Development (HRD) Ministry officials and demanded the removal of Vice-Chancellor M Jagadesh Kumar from his post.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 21,2020

New Delhi, Jan 21: With the IMF lowering India's economic growth estimate for the current fiscal to 4.8 per cent, senior Congress leader P Chidambaram on Tuesday claimed an attack on the world body and its chief economist Gita Gopinath by government ministers was imminent.

He also alleged that the growth figure of 4.8 per cent given by the International Monetary Fund (IMF) is after some "window dressing" and he won't be surprised if it goes even lower.

"Reality check from IMF. Growth in 2019-20 will be BELOW 5 per cent at 4.8 per cent," Chidambaram said in a series of tweets.

"Even the 4.8 per cent is after some window dressing. I will not be surprised if it goes even lower," the former finance minister said.

IMF Chief Economist Gopinath was one of the first to denounce demonetisation, he noted.

"I suppose we must prepare ourselves for an attack by government ministers on the IMF and Dr Gita Gopinath," Chidambaram said.

The IMF lowered India's economic growth estimate for the current fiscal to 4.8 per cent and listed the country's much lower-than-expected GDP numbers as the single biggest drag on its global growth forecast for two years.

In October, the IMF had pegged India economic growth at 6.1 per cent for 2019.

Listing decline in rural demand growth and an overall credit sluggishness for lowering of India forecasts, Gopinath, however, had said the growth momentum should improve next year due to factors like positive impact of corporate tax rate reduction.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.